Document is current
Any future updates will be listed below
-
Authors
Liao, Shuangqing
Huang, Ziqi
Liu, Xiaobing
Wang, Kai
Zheng, Zhi
Li, Yanqi
Liu, Sijin
Dai, Zhuoxin
Yang, Miao
Jiang, Li
Dai, Jigang https://orcid.org/0000-0002-3699-8138
Liu, Quanxing https://orcid.org/0000-0002-6725-385X
-
Funding
Funding for this research was provided by:
Noncommunicable Chronic Diseases-National Science and Technology Major Project (2024ZD0529400 & 2024ZD0529406)
New Chongqing Youth Innovation Talent Project (CSTB2024NSCQ-QCXMX0031)
Chongqing Science and Health Joint Medical Science and Technology Innovation and Key Project (2025GGXM001)
Key Project of the Joint Fund for Regional Innovation and Development under the National Natural Science Foundation of China (U24A20715)
Hematopoietic Acute Radiation Syndrome Medical and Pharmaceutical Basic Research Innovation Center, Ministry of Education of the People’s Republic of China (ARSBIC-B-202405)
- License Information
-
More Information
Article History
Received: 23 December 2025
Accepted: 24 May 2026
First Online: 30 May 2026
Declarations
:
: All animal experiments were conducted in accordance with the GB/T 35892 − 2018 Laboratory animal — Guideline for ethical review of animal welfare (Standardization Administration of China), the ARRIVE 2.0 guidelines, and the 3R principles. The experimental protocol was reviewed and approved by the Laboratory Animal Welfare and Ethics Committee of the Army Medical University (AMUWEC20255419). Our IHC sections have been approved by the ethics review board of Aifang Biological Company (Changsha, China; HN20250401).
: Not commissioned, externally peer-reviewed.
: This study does not involve.
: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
